filmov
tv
opGen
0:08:17
OpGen: Encouraging top-line data from Unyvero urinary tract infection (UTI) panel
0:13:16
OpGen - Leadership in the global fight against antimicrobial resistance
0:06:03
OpGen Technology Making a Difference in the Fight Against Antimicrobrial Resistance
0:03:21
Ares-genetics.cloud from OpGen company Ares Genetics
0:20:41
OpGen - Edison Open House: Global Healthcare 2021
0:10:17
OpGen - Edison Open House: Global Healthcare 2022
0:16:26
Opgen Argus DNA optical mapping system part 1 - processor
0:00:42
“The Buzz'' Show: OpGen, Inc. (NASDAQ: OPGN) FDA Clearance for Acuitas® AMR Gene Panel
0:04:56
OpGen's Exciting Future Fighting Antimicrobial Resistance
0:28:10
OpGen (OPGN) - Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference
0:20:35
OpGen CEO Oliver Schacht Appears on Infection Control Today
0:10:17
OpGen: Edison Open House Healthcare 2022
0:01:32
OpGen Stock Analysis OPGN Biotechnology Industry Analysis Tariffs Impact
0:05:22
OpGen: Upside in the fight against superbugs?
0:20:33
Fighting Infections with Genomic Testing: Evan Jones of OpGen Describes Exciting New Technology
0:24:29
Opgen-Rhein: 'Infradiaphragmatic malformations'
0:42:33
Oliver Schacht, CEO of OPGN, Speaks to StoryTrading About OpGen and Molecular Diagnostics
0:00:20
🔴 OpGen Inc OPGN Stock Information 🔴
0:33:16
F130 How Can We Optimize the Use of Antibiotics? (Oliver Schacht, OpGen)
0:06:43
OpGen CEO Oliver Schacht Appears on EdisonTV to Discuss the Future of the Combined Company
0:18:48
Opgen Argus DNA Optical mapping system part 2
0:19:33
OpGen CEO Oliver Schacht on OpGen’s $15m capital raise
0:05:07
Is OpGen a BUY?
Вперёд
visit shbcf.ru
0:08:17
0:13:16
0:06:03
0:03:21
0:20:41
0:10:17
0:16:26
0:00:42
0:04:56
0:28:10
0:20:35
0:10:17
0:01:32
0:05:22
0:20:33
0:24:29
0:42:33
0:00:20
0:33:16
0:06:43
0:18:48
0:19:33
0:05:07